Cerevel Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CERE and buy or sell other stocks, ETFs, and their options commission-free!About CERE
Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease.
CEORonald C. Renaud, Jr., MBA
CEORonald C. Renaud, Jr., MBA
Employees—
Employees—
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2018
Founded2018
Employees—
Employees—
CERE Key Statistics
Market cap8.19B
Market cap8.19B
Price-Earnings ratio-16.46
Price-Earnings ratio-16.46
Dividend yield—
Dividend yield—
Average volume2.06M
Average volume2.06M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$44.99
52 Week high$44.99
52 Week low$19.59
52 Week low$19.59
Stock Snapshot
As of today, Cerevel Therapeutics(CERE) shares are valued at $44.96. The company's market cap stands at 8.19B, with a P/E ratio of -16.46.
On 2025-12-18, Cerevel Therapeutics(CERE) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Cerevel Therapeutics(CERE) stock has reached 0, versus its average volume of 2.06M.
Over the past 52 weeks, Cerevel Therapeutics(CERE) stock has traded between a high of $44.99 and a low of $19.59.
Over the past 52 weeks, Cerevel Therapeutics(CERE) stock has traded between a high of $44.99 and a low of $19.59.
People also own
Based on the portfolios of people who own CERE. This list is generated using Robinhood data, and it’s not a recommendation.